183 results on '"Sang-Bae Kim"'
Search Results
2. Supplementary Figure 1 from The Orphan Nuclear Receptor NR4A1 (Nur77) Regulates Oxidative and Endoplasmic Reticulum Stress in Pancreatic Cancer Cells
3. Supplementary Table 2 from The Orphan Nuclear Receptor NR4A1 (Nur77) Regulates Oxidative and Endoplasmic Reticulum Stress in Pancreatic Cancer Cells
4. Supplementary Figure 2 from The Orphan Nuclear Receptor NR4A1 (Nur77) Regulates Oxidative and Endoplasmic Reticulum Stress in Pancreatic Cancer Cells
5. Supplementary Figure 5 from The Orphan Nuclear Receptor NR4A1 (Nur77) Regulates Oxidative and Endoplasmic Reticulum Stress in Pancreatic Cancer Cells
6. Supplementary Table 1 from The Orphan Nuclear Receptor NR4A1 (Nur77) Regulates Oxidative and Endoplasmic Reticulum Stress in Pancreatic Cancer Cells
7. Supplementary Figure 4 from The Orphan Nuclear Receptor NR4A1 (Nur77) Regulates Oxidative and Endoplasmic Reticulum Stress in Pancreatic Cancer Cells
8. Data from Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer
9. Supplementary Table 3 from The Orphan Nuclear Receptor NR4A1 (Nur77) Regulates Oxidative and Endoplasmic Reticulum Stress in Pancreatic Cancer Cells
10. Supplementary Figure 3 from The Orphan Nuclear Receptor NR4A1 (Nur77) Regulates Oxidative and Endoplasmic Reticulum Stress in Pancreatic Cancer Cells
11. Data from The Orphan Nuclear Receptor NR4A1 (Nur77) Regulates Oxidative and Endoplasmic Reticulum Stress in Pancreatic Cancer Cells
12. Supplemental Data from Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer
13. Data from Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular Carcinoma
14. Figure S6 from Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
15. Data from Gene Expression Signature–Based Prognostic Risk Score in Gastric Cancer
16. Figure S8 from Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
17. Figure S9 from Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
18. Figure S3 from Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
19. Table S1 from Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
20. Supplementary Tables 1-4 from Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set
21. Supplementary Methods from Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
22. Figure S1 from Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
23. Figure S5 from Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
24. Data from Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
25. Figure S2 from Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
26. Data from Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set
27. Figure S7 from Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
28. Supplementary Information, Supplementary References, Supplementary Figures 1-2, Supplementary Tables 1-10 from Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular Carcinoma
29. Supplementary Data from Gene Expression Signature–Based Prognostic Risk Score in Gastric Cancer
30. Supplementary Materials and Methods, Figures 1 - 9, Tables 1 - 7 from Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target
31. Supplementary Figure Legends 1-4 from Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set
32. Supplementary Figures 1-4 from Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set
33. Supplementary Figures S1-S5 from Significant Association of Oncogene YAP1 with Poor Prognosis and Cetuximab Resistance in Colorectal Cancer Patients
34. Data from Significant Association of Oncogene YAP1 with Poor Prognosis and Cetuximab Resistance in Colorectal Cancer Patients
35. Figure S4 from Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
36. Data from Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target
37. Table S3 from Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
38. Supplementary Materials and Methods from CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer
39. Supplementary Figures 1-8 from CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer
40. Supplementary Tables 1 and 2 from CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer
41. Data from Periostin, a Cell Adhesion Molecule, Facilitates Invasion in the Tumor Microenvironment and Annotates a Novel Tumor-Invasive Signature in Esophageal Cancer
42. Supplementary Figure 4 from Periostin, a Cell Adhesion Molecule, Facilitates Invasion in the Tumor Microenvironment and Annotates a Novel Tumor-Invasive Signature in Esophageal Cancer
43. Supplementary Table 2 from Periostin, a Cell Adhesion Molecule, Facilitates Invasion in the Tumor Microenvironment and Annotates a Novel Tumor-Invasive Signature in Esophageal Cancer
44. Supplementary Table 1 from Periostin, a Cell Adhesion Molecule, Facilitates Invasion in the Tumor Microenvironment and Annotates a Novel Tumor-Invasive Signature in Esophageal Cancer
45. Supplementary Figure 2 from Periostin, a Cell Adhesion Molecule, Facilitates Invasion in the Tumor Microenvironment and Annotates a Novel Tumor-Invasive Signature in Esophageal Cancer
46. Supplementary Figure 1 A-C from Periostin, a Cell Adhesion Molecule, Facilitates Invasion in the Tumor Microenvironment and Annotates a Novel Tumor-Invasive Signature in Esophageal Cancer
47. Supplementary Figure 3 from Periostin, a Cell Adhesion Molecule, Facilitates Invasion in the Tumor Microenvironment and Annotates a Novel Tumor-Invasive Signature in Esophageal Cancer
48. Optimum thickness of GaAs top layer in AlGaAs‐based 850 nm VCSELs for 56 Gb/s PAM‐4 applications
49. Effects of Leachates from Hydrothermal Ore Particulates on Life Cycle Parameters and Expression of Defense-Related Genes in the Marine Copepod Tigriopus japonicus
50. Quasi-Static Mode Behavior of Multiple Transverse-Mode VCSELs Under High-Speed Direct Modulation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.